Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metabolic Syndrome and Its Single Traits as Risk Factors of Diabetes in People With Impaired Glucose Tolerance: The STOP-NIDDM Trial

NCT00629213 is registered in ClinicalTrials.gov with GWT-TUD GmbH as lead sponsor.

NCT NCT00629213
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00629213 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metabolic Syndrome and Its Single Traits as Risk Factors of Diabetes in People With Impaired Glucose Tolerance: The STOP-NIDDM Trial
Lead sponsor
GWT-TUD GmbH
Phase
Phase 3
Overall status
Completed
Start date
Not reported
Completion date
Not reported
Enrollment
1,429
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic syndrome